Viewing Study NCT05493293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2026-04-13 @ 12:45 PM
Study NCT ID: NCT05493293
Status: TERMINATED
Last Update Posted: 2024-04-12
First Post: 2022-08-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
Sponsor: Neurocrine Biosciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Focal Onset Seizure View
None Focal Onset Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None epilepsy View
None focal seizure View
None sodium channel View
None voltage-gated View
None alpha subunit View
None Nav1.6 inhibitor View
None antiseizure medicine View
None ASM View
None antiepileptic drug View
None AED View
None partial seizure View
None partial onset epilepsy View